“Cause of Death, Unknown” (A documentary film about antipsychotic medication)

“Cause of Death, Unknown” (A documentary film about antipsychotic medication)
A CPCS MHLD-Approved Two-Credit Hours CLE Program

Sponsored by Kerry Kotar and Norman J. Sherman, CPCS Mental Health
Regional Coordinators

Date of CLE: Thursday, June 16, 2022

Time: 1 p.m. to 3:00 p.m.

Where: On Zoom—Link to be provided upon registration

PROGRAM
Approx 1.5 hour film plus half-hour discussion
Topic: Investigating the Pharma-Medical Industry Development-Use of
Antipsychotic Medication

“After her sister died suddenly and unexpectedly while being treated with prescription
antipsychotics, director Anniken Hoel begins a global investigation into the crimes of
the pharmaceutical industry, the unheralded growth of psychiatric diagnoses and
medication, and the corruption of the government regulatory agencies that have
failed, repeatedly, to protect us. Made over a ten-year period, the film is
simultaneously personal and investigative as it follows Anniken as she seeks answers
regarding not only the death of her sister, but of the tens of thousands worldwide
who have also met a similar fate. Deaths and damages that until now have been all
but ignored. Beginning in a small town in Norway, and journeying through
Scandinavia, the EU and the US, the chilling documentary-thriller CAUSE OF DEATH:
UNKNOWN exposes the inner workings and motivations of a powerful industry that
continually puts profits before people, and has been far too influential in defining
who is normal and who is “ill.”

Attribution:
https://www.imdb.com/title/tt6151226/plotsummary?ref_=tt_ov_pl)

Come prepared to engage in a thoughtful discussion about the film. We look
forward to talking about:
— the interaction (and, perhaps, collaboration) between pharmaceutical
industry’s intense interest in developing psychoactive medications and
subsequent growth of mental illness diagnoses during the past 30+ years

— how government regulatory agencies were involved (and, perhaps, complicit)
in the pharm-medical industry evolution of psychoactive medication and mental
illness diagnosis

— the legal and social implications of these parallel actions by the
pharmaceutical and medical industries

— the assertion that state laws and medical practice surrounding mental illness
and treatment thereof is directly and indirectly influenced by the pharmaceutical
industry; and

— how Respondent’s counsel and their experts may address these issues in our
civil commitment and guardianship cases

TO REGISTER please copy and paste the following link into your web browser and press “enter” on your keyboard:

https://us02web.zoom.us/meeting/register/tZApdu6hpzIiHdUl5J5VcEpzXCzkyNIDr-r5

After registering, you will receive a confirmation email containing information about joining the seminar on June 16, 2022 at 1:00 p.m.

Thank you for your interest in this program.